Oral IR-LD/CD clinical trials

Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations

This study is looking at a new way to give Parkinson's medication, called ND0612, through a pump under the skin. It compares this new method to the usual tablets for people whose Parkinson's symptoms change a lot during the day.